In a recent discussion with The New York Times, CEO Tom Hale of Oura Health refrained from addressing rumors about potential new funding for the health-tracking ring company. However, he did touch upon the possibility of taking Oura public in the future.
Oura Health CEO Tom Hale, in a recent interview with The New York Times, avoided commenting on the speculations surrounding the company’s potential new funding that could value the health-tracking ring maker at almost $11 billion. Instead, he hinted at the prospect of making Oura a publicly-traded entity.
Regarding the company’s financial performance, Oura recently disclosed its projection to achieve $1 billion in revenue this year, marking a significant increase from its earnings in 2024.
During the interview, Tom Hale also shared insights into his personal sleep routine, averaging 7.5 hours per night. Additionally, he discussed Oura’s involvement in data-sharing initiatives initiated by the Trump administration, emphasizing the importance of customer data privacy and security.
